PWM
IDXX icon

Parkworth Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Parkworth Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.07K Buy
2
+1
+100% +$478 ﹤0.01% 394
2025
Q1 		$420 Hold
1
– – ﹤0.01% 478
2024
Q4 		$413 Buy
+1
New +$439 ﹤0.01% 492

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parkworth Wealth Management's IDXX Position: Q2 2025 in Review

Parkworth Wealth Management increased its Idexx Laboratories (IDXX) stake by 100% in Q2 2025, buying an estimated $478 and bringing the position to 2 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #394.

Parkworth Wealth Management first reported a position in IDXX in Q4 2024 and has held it in 3 quarters since. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Parkworth Wealth Management held 2 shares of Idexx Laboratories worth $1.07K as of Q2 2025.
  • Parkworth Wealth Management bought 1 Idexx Laboratories share in Q2 2025, an estimated $478.
  • Idexx Laboratories made up ﹤0.01% of Parkworth Wealth Management's portfolio in Q2 2025, its #394 holding.
  • Parkworth Wealth Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 3 quarters since.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Parkworth Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.